PTC Therapeutics, Inc. (PTCT)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:15PM EDT. Market open.
Loading interactive chart…
- Simply Wall St.
Investing in PTC Therapeutics (NASDAQ:PTCT) five years ago would have delivered you a 173% gain
The worst result, after buying shares in a company (assuming no leverage), would be if you lose all the money you put...
- Motley Fool
ClearPoint Neuro, Inc. (CLPT) Q2 2022 Earnings Call Transcript
Good afternoon, everyone, and thank you to all of the investors and analysts on today's call for being a part of the ClearPoint vision and journey. In the first half of 2022, we continue to make progress across our four-pillar growth strategy, including biologics and drug delivery, functional neurosurgery navigation, therapy and access products, and in achieving global scale.
- Zacks
PTC Therapeutics (PTCT) Reports Q2 Loss, Tops Revenue Estimates
PTC Therapeutics (PTCT) delivered earnings and revenue surprises of -27.54% and 13.54%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
© 2022 Yahoo. All rights reserved.
